Ketrovis-10

Description

Ketrovis-10 is an ANVIS product. Its packaging identifies Ketorolac tromethamine USP in tablets form. This entry records the visible product specification and shows the original carton with the tablet blister outside it.

Ketrovis-10 product specification

• Product name: Ketrovis-10
• Ingredient: Ketorolac tromethamine USP
• Product designation: 10, as displayed on the carton
• Dosage form: Tablets
• Presentation: 2 × 15 tablets (30 tablets)
• Brand: ANVIS

First, match the full name, strength and formulation to the item supplied. For example, a different strength needs separate identification. Packaging details describe the presentation; they do not establish a dose or treatment duration. Therefore, consult the supplied leaflet and your healthcare professional before use.

General information about ketorolac

Ketorolac is an NSAID for short-term treatment of moderately severe pain. It is not a routine treatment for mild or chronic pain. MedlinePlus describes oral treatment after initial injection and a total course of no more than five days. Therefore, follow your prescriber’s instructions and the leaflet for your exact product.

Ketrovis-10: important safety warnings

Ketorolac can cause stomach bleeding, ulcers, kidney injury, heart attack or stroke. Before treatment, discuss previous ulcers or bleeding, dehydration, kidney or heart disease and all other medicines. Also report pregnancy, breastfeeding and any NSAID allergy. Do not combine it with aspirin, ibuprofen or another NSAID without specialist advice.

Seek urgent help for black stools, vomiting blood, chest pain, breathing difficulty or sudden weakness. In addition, contact your clinician if pain persists. Do not extend the prescribed course. The 30-tablet pack quantity does not authorize a longer treatment period.

Documentation and product enquiries

The MedlinePlus ketorolac guide provides background on the ingredient, not the complete specification of this ANVIS product. Review the supplied leaflet for current local instructions. For further Ketrovis-10 documentation, contact ANVIS with the product name and presentation. Alternatively, browse our tablet catalogue.